12-01 :: January 2012
nanotimes
Companies Facts
S
IJTechnology, IOX Co., NGK Spark Plug Co., Osaka Municipal Technical Research Institute
(OMTRI), and the National Institute of Advanced Industrial Science and Technology (AIST) have jointly realized ultra-fine wires with a line width of 5μm and specific resistivity of 8.1 μΩ • cm through the research commissioned by the New Energy and Industrial Technology Development Organization (NEDO). The wires were fabricated by direct pat- terning with an inkjet technology and a technology for reduction under extremely-low oxygen partial pressure. The wires are expected to contribute to the development of next-generation IC boards and micro printed circuit boards for cell phones and IC tags.
in itself – and also serves as an excellent primer to prepare the wheel for subsequent bespoke painting. By this STARCO is using the latest automotive nano- technology pre-treatment. The whole system is an environmentally friendly process due to the design and the nanotechnology implemented.
tarpharma (OTCQX SPHRY) has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel®
for the
treatment of bacterial vaginosis (BV) under the FDA’s Special Protocol Assessment (SPA) scheme.
“Receiving this SPA agreement gives Starpharma gre- at confidence in our Phase 3 program, and allows us to proceed through this final development stage with a high level of clarity about the approval pathway for VivaGel®
for treatment of BV,” said Dr Jackie Fair- ley, Chief Executive Officer of Starpharma.
Image: Developed technology (line width: 5μm; pitch: 10μm), © SIJTechnology
http://www.sijtechnology.com S
ince the beginning of this year, STARCO in Denmark has started using the new e-coat plant
that was installed and commissioned in Q4, 2011 at its wheel factory in Beli Manastir, Croatia. The e-coat facility is an electrostatic coating process, in which steel wheels are given a priming coat that will pre- vent rust and corrosion throughout the normal wor- king life of the wheel. The coating which is applied in this process serves as a rust prevention coating
Moreover, Starpharma announced the advance- ment of its drug delivery collaboration with US pharmaceutical corporation Eli Lilly and Company. Starpharma has a number of projects underway with Lilly to improve the delivery of small molecule and protein-based pharmaceuticals using Starpharma’s dendrimer technology. Starpharma also released its Appendix 4C - Quarterly Cashflow report for the period ended December 31, 2011. The cash balance at end of December 2011 was $49m, which includes proceeds of $35m (before costs) from the successful capital raising conducted in November 2011. Total operating and investing cash outflow for the quarter was $1.8m. These funds
39